Camp4 Therapeutics Corp — Investor Relations & Filings
Camp4 Therapeutics Corp. is a clinical-stage biopharmaceutical company that develops programmable therapeutics for a range of genetic diseases. The company pioneers an approach centered on regulatory RNA (regRNA) to modulate gene expression and amplify the production of healthy proteins. Its core technology involves RNA Actuators, a class of antisense oligonucleotides (ASOs), which are designed to restore protein levels to a healthy range. Camp4 utilizes its proprietary RNA Actuating Platform (RAP) to discover and advance its pipeline of potential disease-modifying treatments, with a focus on rare genetic conditions where upregulating protein expression may offer therapeutic benefits.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Camp4 Therapeutics Corp (0001736730) (Filer) | 2026-04-23 | English | |
| DEF 14A - Camp4 Therapeutics Corp (0001736730) (Filer) | 2026-04-23 | English | |
| 8-K - Camp4 Therapeutics Corp (0001736730) (Filer) | 2026-03-24 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| SCHEDULE 13G/A Filing | 2026-02-05 | English | |
| 8-K | 2026-01-09 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 35695391 | ARS - Camp4 Therapeutics Corp (0001736730) (Filer) | 2026-04-23 | English | ||
| 35694045 | DEF 14A - Camp4 Therapeutics Corp (0001736730) (Filer) | 2026-04-23 | English | ||
| 33026880 | 8-K - Camp4 Therapeutics Corp (0001736730) (Filer) | 2026-03-24 | English | ||
| 31527962 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31527923 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 13102831 | 8-K | 2026-01-09 | English | ||
| 13102832 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
|
2025
8 filings
| |||||
| 13102836 | Major Shareholding Notification 2025 | 2025-12-23 | English | ||
| 13102835 | 8-K | 2025-12-23 | English | ||
| 13102833 | FORM 4 | 2025-12-22 | English | ||
| 13102838 | FORM 4 | 2025-12-22 | English | ||
| 13102837 | FORM 4 | 2025-12-22 | English | ||
| 13102839 | FORM 4 | 2025-12-22 | English | ||
| 13102840 | 8-K | 2025-12-18 | English | ||
| 13102841 | 424B5 | 2025-12-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
Camp4 Therapeutics Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34473/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34473 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34473 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34473 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34473}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Camp4 Therapeutics Corp (id: 34473)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.